Genomics

Dataset Information

EP300/CREBBP acetyltransferase inhibition limits steroid receptor and FOXA1 signaling in prostate cancer cells (ATAC-seq)


ABSTRACT: EP300/CREBBP acetyltransferase inhibition limits steroid receptor and FOXA1 signaling in prostate cancer cells (ATAC-seq)

PROVIDER: PRJNA1030764 | ENA |

REPOSITORIES: ENA